Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Drug Delivery Systems: HELP
Twan Lammers
Based on 64 articles published since 2009
(Why 64 articles?)
||||
Expertise Level
The expertise of Twan Lammers ranks in the
  • Top 0.0049%
  • ... of 202,057 published authors worldwide on Drug Delivery Systems
  • ... from 2009 through 2019
  • ... based on contributions to 64 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Lammers, T   ·   Lammers, Twan
Work Locations
Details
Most likely:    RWTH Aachen      
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
  • Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Imaging Division, University Medical Center Utrecht, Utrecht, The Netherlands; and. · Department of Medical Engineering, Ruhr-University Bochum, Bochum, Germany. · Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany · Pubmed 29496981
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584, CG, Utrecht, The Netherlands. · Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, 7522, NB, Enschede, The Netherlands. · Pubmed 29152858
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. Electronic address: · Pubmed 28552267
  • Department of Polymer Chemistry and Bioengineering, Zernike Institute for Advanced Materials, Faculty of Mathematics and Natural Sciences, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. · W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, 9713 AV Groningen, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522 NB Enschede, The Netherlands. · Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28154410
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • School of Bioscience and Bioengineering, South China University of Technology, 510006, Guangzhou, China. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, 7522, NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584, CG, The Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands. · Pubmed 27413999
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Institute for Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Institute of Chemistry and Biology of Membranes and Nano-objects, CBMN UMR 5248, Bordeaux University , 33608 Pessac, France. · Department of Pharmaceutics, UIPS, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research IMCAR, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429 Bergisch Gladbach, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University Mainz , Duesbergweg 10-14, 55099 Mainz, Germany. · Max Planck Institute for Polymer Research , Ackermannweg 10, 55128 Mainz, Germany. · Institute of Organic Chemistry, RWTH Aachen , Landoltweg 1, 52074 Aachen, Germany. · Department of Targeted Therapeutics, University of Twente , P.O. Box 217, 750 AE Enschede, The Netherlands. · Pubmed 28715227
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. and Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Pubmed 28702658
  • Institute of Chemistry & Biology of Membranes & Nanoobjects (CBMN), UMR 5248, University of Bordeaux, Pessac, France. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Fujifilm VisualSonics BV, Amsterdam, the Netherlands. · Pubmed 28572726
  • School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China. · Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin 300071, China. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. · School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China. Electronic address: · Pubmed 28527734
  • Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Pauwelsstrasse 30, 52074, Aachen, Germany. · Electron Microscopic Facility, University Hospital RWTH, Pauwelsstrasse 30, 52074, Aachen, Germany. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstrasse 50, 52056, Aachen, Germany. · Pubmed 28371270
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 27986222
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 26969576
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 26795193
  • Institute of Chemistry & Biology of Membranes & Nano-objects, CBMN UMR 5248, Bordeaux University , 33600 Pessac, France. · Experimental Molecular Imaging, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Gastroenterology and Metabolic Disorders, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Pubmed 27412680
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute for Laboratory Animal Science, University Clinic, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 26878973
2015
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Pubmed 25969868
  • †Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CG, The Netherlands. · ‡Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands. · §Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, RWTH Aachen University Clinic, Aachen 52074, Germany. · ∥Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede 7500 AE, The Netherlands. · Pubmed 25831471
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · InnoCore Pharmaceuticals, Groningen, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 25701807
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 25636301
2014
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Controlled Dug Delivery, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24316070
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23485339
2012
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Pubmed 21945285
2011
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Pubmed 21545096
2015
  • RWTH Aachen University, University Clinic and Helmholtz Institute for Biomedical Engineering, Institute for Experimental Molecular Imaging (ExMI), Department of Nanomedicines and Theranostics , Pauwelsstrasse 30, 52074 Aachen , Germany. · Pubmed 26083469
2014
  • Department of Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 24422585
2013
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23578464
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Pubmed 23067565
2012
  • Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Pubmed 22393225
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 22214503
  • Department of Pharmaceutical Sciences, Mahatma Gandhi University, Cheruvandoor campus, Ettumanoor, Kerala, India. · Pubmed 21631585
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Center for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Pubmed 22580225
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Germany. · Pubmed 22344881
Probable:    Universiteit Utrecht      
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584, CG, Utrecht, The Netherlands. · Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, 7522, NB, Enschede, The Netherlands. · Pubmed 29152858
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Polymer Chemistry and Bioengineering, Zernike Institute for Advanced Materials, Faculty of Mathematics and Natural Sciences, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. · W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, 9713 AV Groningen, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522 NB Enschede, The Netherlands. · Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28154410
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • School of Bioscience and Bioengineering, South China University of Technology, 510006, Guangzhou, China. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, 7522, NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584, CG, The Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands. · Pubmed 27413999
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. and Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Pubmed 28702658
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 27986222
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute for Laboratory Animal Science, University Clinic, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 26878973
2015
  • †Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CG, The Netherlands. · ‡Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands. · §Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, RWTH Aachen University Clinic, Aachen 52074, Germany. · ∥Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede 7500 AE, The Netherlands. · Pubmed 25831471
2014
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 20822168
2015
  • Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Department of Pharmaceutics , 3584 CG Utrecht , The Netherlands · Pubmed 25425332
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 25929568
2014
  • Image Sciences Institute, University Medical Center Utrecht, Utrecht, Netherlands. · Pubmed 24706612
2013
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 23122804
2012
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 22226771
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 22692876
2011
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 21901211
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, Utrecht, The Netherlands. · Pubmed 21262289
  • Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Pubmed 21118719
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 21529659
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 21049986
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 20673684
2009
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, P.O. Box 80082, 3508 TB Utrecht, The Netherlands. · Pubmed 19166276
Probable:    Universiteit Twente      
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
  • Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Imaging Division, University Medical Center Utrecht, Utrecht, The Netherlands; and. · Department of Medical Engineering, Ruhr-University Bochum, Bochum, Germany. · Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany · Pubmed 29496981
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584, CG, Utrecht, The Netherlands. · Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, 7522, NB, Enschede, The Netherlands. · Pubmed 29152858
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Polymer Chemistry and Bioengineering, Zernike Institute for Advanced Materials, Faculty of Mathematics and Natural Sciences, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. · W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, 9713 AV Groningen, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522 NB Enschede, The Netherlands. · Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28154410
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • School of Bioscience and Bioengineering, South China University of Technology, 510006, Guangzhou, China. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, 7522, NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584, CG, The Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands. · Pubmed 27413999
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Institute for Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Institute of Chemistry and Biology of Membranes and Nano-objects, CBMN UMR 5248, Bordeaux University , 33608 Pessac, France. · Department of Pharmaceutics, UIPS, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research IMCAR, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429 Bergisch Gladbach, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University Mainz , Duesbergweg 10-14, 55099 Mainz, Germany. · Max Planck Institute for Polymer Research , Ackermannweg 10, 55128 Mainz, Germany. · Institute of Organic Chemistry, RWTH Aachen , Landoltweg 1, 52074 Aachen, Germany. · Department of Targeted Therapeutics, University of Twente , P.O. Box 217, 750 AE Enschede, The Netherlands. · Pubmed 28715227
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. and Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Pubmed 28702658
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 27986222
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 26969576
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 26795193
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute for Laboratory Animal Science, University Clinic, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 26878973
2015
  • †Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CG, The Netherlands. · ‡Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands. · §Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, RWTH Aachen University Clinic, Aachen 52074, Germany. · ∥Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede 7500 AE, The Netherlands. · Pubmed 25831471
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · InnoCore Pharmaceuticals, Groningen, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 25701807
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 25636301
2014
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Controlled Dug Delivery, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24316070
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 64 total) written by Twan Lammers about Drug Delivery Systems:

  • Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation. 2018
  • Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies. 2018
  • Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors. 2018
  • Advanced Ultrasound Technologies for Diagnosis and Therapy. 2018
  • In Vitro Evaluation of Anti-Aggregation and Degradation Behavior of PEGylated Polymeric Nanogels under In Vivo Like Conditions. 2018
  • Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. 2017
  • Recent advances in ultrasound-based diagnosis and therapy with micro- and nanometer-sized formulations. 2017
  • Targeting iron metabolism in drug discovery and delivery. 2017
  • Tumor-targeted nanomedicines for cancer theranostics. 2017
  • Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery. 2017
Show List of Full Article Records
Google Searches

Learn more about Twan Lammers using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
RWTH Aachen
Universiteit Utrecht
Universiteit Twente
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
RWTH Aachen
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
  • Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Imaging Division, University Medical Center Utrecht, Utrecht, The Netherlands; and. · Department of Medical Engineering, Ruhr-University Bochum, Bochum, Germany. · Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany · Pubmed 29496981
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584, CG, Utrecht, The Netherlands. · Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, 7522, NB, Enschede, The Netherlands. · Pubmed 29152858
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. Electronic address: · Pubmed 28552267
  • Department of Polymer Chemistry and Bioengineering, Zernike Institute for Advanced Materials, Faculty of Mathematics and Natural Sciences, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. · W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, 9713 AV Groningen, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522 NB Enschede, The Netherlands. · Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28154410
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • School of Bioscience and Bioengineering, South China University of Technology, 510006, Guangzhou, China. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, 7522, NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584, CG, The Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands. · Pubmed 27413999
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Institute for Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Institute of Chemistry and Biology of Membranes and Nano-objects, CBMN UMR 5248, Bordeaux University , 33608 Pessac, France. · Department of Pharmaceutics, UIPS, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research IMCAR, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429 Bergisch Gladbach, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University Mainz , Duesbergweg 10-14, 55099 Mainz, Germany. · Max Planck Institute for Polymer Research , Ackermannweg 10, 55128 Mainz, Germany. · Institute of Organic Chemistry, RWTH Aachen , Landoltweg 1, 52074 Aachen, Germany. · Department of Targeted Therapeutics, University of Twente , P.O. Box 217, 750 AE Enschede, The Netherlands. · Pubmed 28715227
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. and Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Pubmed 28702658
  • Institute of Chemistry & Biology of Membranes & Nanoobjects (CBMN), UMR 5248, University of Bordeaux, Pessac, France. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Fujifilm VisualSonics BV, Amsterdam, the Netherlands. · Pubmed 28572726
  • School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China. · Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin 300071, China. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. · School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China. Electronic address: · Pubmed 28527734
  • Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Pauwelsstrasse 30, 52074, Aachen, Germany. · Electron Microscopic Facility, University Hospital RWTH, Pauwelsstrasse 30, 52074, Aachen, Germany. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstrasse 50, 52056, Aachen, Germany. · Pubmed 28371270
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 27986222
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 26969576
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 26795193
  • Institute of Chemistry & Biology of Membranes & Nano-objects, CBMN UMR 5248, Bordeaux University , 33600 Pessac, France. · Experimental Molecular Imaging, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Gastroenterology and Metabolic Disorders, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Pubmed 27412680
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute for Laboratory Animal Science, University Clinic, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 26878973
2015
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Pubmed 25969868
  • †Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CG, The Netherlands. · ‡Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands. · §Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, RWTH Aachen University Clinic, Aachen 52074, Germany. · ∥Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede 7500 AE, The Netherlands. · Pubmed 25831471
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · InnoCore Pharmaceuticals, Groningen, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 25701807
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 25636301
2014
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Controlled Dug Delivery, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24316070
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23485339
2012
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Pubmed 21945285
2011
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Pubmed 21545096
2015
  • RWTH Aachen University, University Clinic and Helmholtz Institute for Biomedical Engineering, Institute for Experimental Molecular Imaging (ExMI), Department of Nanomedicines and Theranostics , Pauwelsstrasse 30, 52074 Aachen , Germany. · Pubmed 26083469
2014
  • Department of Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 24422585
2013
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23578464
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Pubmed 23067565
2012
  • Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Pubmed 22393225
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 22214503
  • Department of Pharmaceutical Sciences, Mahatma Gandhi University, Cheruvandoor campus, Ettumanoor, Kerala, India. · Pubmed 21631585
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Center for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Pubmed 22580225
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Germany. · Pubmed 22344881
Universiteit Utrecht
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584, CG, Utrecht, The Netherlands. · Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, 7522, NB, Enschede, The Netherlands. · Pubmed 29152858
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Polymer Chemistry and Bioengineering, Zernike Institute for Advanced Materials, Faculty of Mathematics and Natural Sciences, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. · W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, 9713 AV Groningen, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522 NB Enschede, The Netherlands. · Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28154410
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • School of Bioscience and Bioengineering, South China University of Technology, 510006, Guangzhou, China. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, 7522, NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584, CG, The Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands. · Pubmed 27413999
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. and Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Pubmed 28702658
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 27986222
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute for Laboratory Animal Science, University Clinic, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 26878973
2015
  • †Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CG, The Netherlands. · ‡Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands. · §Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, RWTH Aachen University Clinic, Aachen 52074, Germany. · ∥Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede 7500 AE, The Netherlands. · Pubmed 25831471
2014
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 20822168
2015
  • Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Department of Pharmaceutics , 3584 CG Utrecht , The Netherlands · Pubmed 25425332
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 25929568
2014
  • Image Sciences Institute, University Medical Center Utrecht, Utrecht, Netherlands. · Pubmed 24706612
2013
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 23122804
2012
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 22226771
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 22692876
2011
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 21901211
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, Utrecht, The Netherlands. · Pubmed 21262289
  • Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Pubmed 21118719
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 21529659
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 21049986
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 20673684
2009
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, P.O. Box 80082, 3508 TB Utrecht, The Netherlands. · Pubmed 19166276
Universiteit Twente
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
  • Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Imaging Division, University Medical Center Utrecht, Utrecht, The Netherlands; and. · Department of Medical Engineering, Ruhr-University Bochum, Bochum, Germany. · Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany · Pubmed 29496981
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584, CG, Utrecht, The Netherlands. · Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, 7522, NB, Enschede, The Netherlands. · Pubmed 29152858
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Polymer Chemistry and Bioengineering, Zernike Institute for Advanced Materials, Faculty of Mathematics and Natural Sciences, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. · W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, 9713 AV Groningen, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522 NB Enschede, The Netherlands. · Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28154410
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • School of Bioscience and Bioengineering, South China University of Technology, 510006, Guangzhou, China. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, 7522, NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584, CG, The Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands. · Pubmed 27413999
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Institute for Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Institute of Chemistry and Biology of Membranes and Nano-objects, CBMN UMR 5248, Bordeaux University , 33608 Pessac, France. · Department of Pharmaceutics, UIPS, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research IMCAR, RWTH Aachen , Pauwelsstrasse 30, 52074 Aachen, Germany. · Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429 Bergisch Gladbach, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University Mainz , Duesbergweg 10-14, 55099 Mainz, Germany. · Max Planck Institute for Polymer Research , Ackermannweg 10, 55128 Mainz, Germany. · Institute of Organic Chemistry, RWTH Aachen , Landoltweg 1, 52074 Aachen, Germany. · Department of Targeted Therapeutics, University of Twente , P.O. Box 217, 750 AE Enschede, The Netherlands. · Pubmed 28715227
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. and Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074 Aachen, Germany and Department of Targeted Therapeutics, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, 7522 NB, The Netherlands. · Pubmed 28702658
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 27986222
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 26969576
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 26795193
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute for Laboratory Animal Science, University Clinic, RWTH-Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 26878973
2015
  • †Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CG, The Netherlands. · ‡Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands. · §Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, RWTH Aachen University Clinic, Aachen 52074, Germany. · ∥Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede 7500 AE, The Netherlands. · Pubmed 25831471
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · InnoCore Pharmaceuticals, Groningen, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: · Pubmed 25701807
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany; Department of Controlled Drug Delivery, University of Twente, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 25636301
2014
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Controlled Dug Delivery, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24316070
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
Helmholtz-Gemeinschaft
2009
  • Department of Innovative Cancer Diagnosis and Therapy, DKFZ Heidelberg, German Cancer Research Center, Germany. · Pubmed 19304320
3 Other Locations Show
Yearly article counts 0514684511452
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.